# US 2008/0306268 A1 · Crystalline clopidogrel hydrobromide and processes for preparation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306268 A1
- Document ID: US20080306268A1
- Status: Published application
- Kind: A1
- Application number: 12/221,350
- Filed: 2008-07-31
- Published: 2008-12-11
- Earliest claimed: 2004-09-21
- Assignees: Teva Pharmaceuticals USA, Inc. for Barbados
- Inventors: Nina Finkelstein; Judith Aronhime
- Web page: https://patentgrep.com/patent/US20080306268A1

## CPC

- C07D 495/04: Ortho-condensed systems
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 9/04: Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided are crystalline forms of clopidogrel hydrobromide and processes for their preparation.

## Claims

### Claim 1

A process for preparing the crystalline Form II of clopidogrel hydrobromide, having a melting point within the range of about 124° C. to about 138° C., characterized by a powder X-ray diffraction pattern with peaks at 9.6, 10.5, 14.3, 16.2 and 23.1±0.2 deg. 2-theta comprising the steps of:
(a) preparing a solution of clopidogrel hydrobromide in methyl acetate at a reflux temperature;
(b) crystallizing the crystalline form; and
(c) recovering the crystalline form.

### Claim 2 (depends on 1)

The process of claim 1, wherein the crystallization is induced by cooling to room temperature or lower.
